Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

e-Poster Display Session

294P - Interventional pain treatment in patients with pain syndrome in advanced tumours of small pelvis

Date

22 Nov 2020

Session

e-Poster Display Session

Topics

Supportive and Palliative Care

Tumour Site

Presenters

Yakhyo Ziyaev

Citation

Annals of Oncology (2020) 31 (suppl_6): S1355-S1357. 10.1016/annonc/annonc361

Authors

Y. Ziyaev1, M.N. Tillyashaykhov2, H. Islamov2, Y. Ten3, D. Gaipov4, S. Djanklich5, R. Norbaev6

Author affiliations

  • 1 Palliative Care, National Cancer Research Center, 100179 - Tashkent/UZ
  • 2 Administtration, National Cancer Research Center, 100179 - Tashkent/UZ
  • 3 Coloproctology, National Cancer Research Center, 100179 - Tashkent/UZ
  • 4 Icu, National Cancer Research Center, 100179 - Tashkent/UZ
  • 5 Gynecologic Oncology Department, Republican Specialized Scientific Practical Medical Center of Oncology and Radiology, 100179 - Tashkent/UZ
  • 6 Science, National Cancer Research Center, 100179 - Tashkent/UZ

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 294P

Background

More than a third of small pelvis cancer cases in Uzbekistan are diagnosed in the late stages, where the main goal of medical interventions is to increase life expectancy with maximum maintenance of the quality of life. Opioid prescription and opiophobia in medical personnel make it harder to control pain in this group of patients, decreasing the quality of their life.

Methods

34 patients with locally advanced tumors of small pelvis (17 rectal cancer, 11 cervical cancer, 6 prostate cancer) with pain syndrome by visual analog scale (VAS) 8-10 were selected as the study group. Patients were treated in National cancer center of Uzbekistan in 2017-2020. Epidural catheter was placed in V4-5. Solution of bupivacaine 2.5% 20 ml with 1% of morphine injected at primary point. Then, 5 ml of bupivacaine 2.5% every 6 hours, 1 ml of 1% morphine every 12 hrs. Mean period of catheter placement was 23,6 days (7-36). in order to decrease the possibility of infection wide spectrum of antibiotics and wound dressing were administered. Control group included 34 patients with locally advanced tumors of small pelvis (20 rectal cancer, 12 cervical cancer, 2 prostate cancer) with pain syndrome by visual analog scale (VAS) 8-10. They underwent standard WHO pain ladder therapy morphine 1%-1 ml every 4-6 hrs ± ketorolac 30 mg – 1 ml.

Results

Withing the 20 minutes of administering, median pain syndrome by VAS was 0.78 (0-4). 6 (17.6%) patients admitted headache, 3 dizziness (8.8%). 2 patients admitted 1st grade nausea (5.9%). Constipation was not admitted in the main group. Drowsiness was admitted in 7 patients (20.6%). All of the symptoms disappeared within the 7 days period of hospitalization. In control group, the mean pain syndrome was 4.6 (0-7) by VAS. Drowsiness effect was observed in 27 patients (79.4), however, 21 (61.8%) cases this effect regressed in 7-day period. In 3-months observation period, 11 (32.6) patients from second group had complains on constipation which was resolved with laxatives and enemas.

Conclusions

Analgesia with usage of long-term epidural catheter placement allowed to achieve better pain control, lower opioid usage and avoid severe complications in patients with severe chronic pain syndrome of small pelvis tumors.

Clinical trial identification

N/A

Editorial acknowledgement

Legal entity responsible for the study

National Cancer Center of Uzbekistan.

Funding

National Cancer Center of Uzbekistan.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.